title: [Cardiovascular pharmaceuticals: a risk while driving vehicles].
abstract: OBJECTIVE
  To categorize cardiovascular pharmaceuticals according to their respective effect on one's capacity to drive a vehicle.
  
  
  METHODS
  an analysis of the technical file for 299 pharmaceutical products belonging to 1 lsubgroups inside the main category of therapeutic products related to the cardiovascular apparatus. Information compiled includes: the existence, or lack of, a section which warns of the possible effects of the medication on a person's capacity to drive a vehicle; in those affirmative cases, a statement specifying those effects.
  
  
  CONCLUSIONS
  32.1% of pharmaceutical products do not comply with the existing legislation and approximately half of those pharmaceutical products do not have a section on their effects on a person's capacity to drive a vehicle, or they state these products have an effect but do not bear an influence even though they can provoke important effects.
authors.affiliation: EUE Casade Salud Valdecilla, Universidad de Cantabria. alconear@unican.es
authors.forename: Ana Rosa
authors.initials: AR
authors.lastname: Alconero Camarero
authors.forename: Ana
authors.initials: A
authors.lastname: Sangrador Rasero
authors.forename: María
authors.initials: M
authors.lastname: Casaus Pérez
authors.forename: Luz Elena
authors.initials: LE
authors.lastname: Mirones Valdeolivas
authors.forename: Pedro
authors.initials: P
authors.lastname: Muñoz Cacho
mesh_terms: D001334:Automobile Driving; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004348:Drug Labeling / Q000706:statistics & numerical data*; D006801:Humans; D012307:Risk Factors